Curis | CRIS - ДОЛГ





ДОЛГ Изменить Дата
Alaunos Therapeutics USD 10.99M 5.78M 2023-03
Amgen USD 57.32B 2.72B 2026-03
AstraZeneca USD 32.24B 1.68B 2026-06
Bayer EUR 36.45B 2.93B 2025-12
Bristol-Myers Squibb USD 46.43B 711M 2026-03
CSL USD 11.96B 219M 2024-12
Curis USD 0 0 2022-06
Eli Lilly USD 43.37B 867M 2026-03
Exelixis USD 165.93M 3.61M 2026-06
Gilead Sciences USD 22.17B 2.76B 2026-03
GlaxoSmithKline GBP 19.06B 1.34B 2026-03
Incyte USD 38.27M 1.16M 2026-06
Merck USD 49.12B 222M 2026-03
Novartis USD 49.01B 2.02B 2026-06
Pfizer USD 63.19B 536M 2026-06
Roche Holding CHF 33.03B 1.41B 2025-06
Sanofi EUR 23.58B 3.56B 2026-06
Takeda JPY 4.94T 58.13B 2026-06
TG Therapeutics USD 754.44M 884K 2026-06
Verastem USD 66.79M 26.7M 2024-09